Akebia Therapeutics
AKBA
#6794
Rank
C$0.65 B
Marketcap
$2.52
Share price
-5.85%
Change (1 day)
24.84%
Change (1 year)

P/S ratio for Akebia Therapeutics (AKBA)

P/S ratio as of April 2025 (TTM): 2.85

According to Akebia Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -9.27. At the end of 2024 the company had a P/S ratio of 2.66.

P/S ratio history for Akebia Therapeutics from 2014 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20242.66121.29%
20231.20230.14%
20220.3636-80.36%
20211.8535.09%
20201.37-40.3%
20192.30-26.23%
20183.11-21.21%
20173.95-98.48%
2016260
2015N/A
2014N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.81 69.08%๐Ÿ‡บ๐Ÿ‡ธ USA
4.08 43.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
4.20 47.61%๐Ÿ‡บ๐Ÿ‡ธ USA
1.06-62.84%๐Ÿ‡บ๐Ÿ‡ธ USA